Clinical Trial Update: Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial using a dendritic cell vaccine in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED